Cate Hathaway - GrainCorp Executive
| GRCLF Stock | USD 4.92 0.28 5.38% |
Executive
Ms. Cate Hathaway is Interim Group General Manager Human Resources and SHE of the Company. to cover for Phil Caris while he is on parental leave. Ms Hathaway is a highly experienced HR and SHE practitioner with over 20 years experience with companies including Boral, Westpac and Equifax. She is a Fellow of the Australian Human Resources Institute and member of its Inclusion and Diversity Advisory Panel. Ms Hathaway is also a member of the School of Business, External Advisory Committee at Western Sydney University and a Director of the Board of the Environmental Defenders Office NSW. since 2018.
| Tenure | 6 years |
| Phone | 61 2 9325 9100 |
| Web | https://www.graincorp.com.au |
GrainCorp Management Efficiency
The company has return on total asset (ROA) of 0.2022 % which means that it generated a profit of $0.2022 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2863 %, meaning that it generated $0.2863 on every $100 dollars invested by stockholders. GrainCorp's management efficiency ratios could be used to measure how well GrainCorp manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Paul Hickman | Golden Agri Resources | 57 | |
| Kevin Leggat | Recursion Pharmaceuticals | N/A | |
| Sanjeev Khindri | Aerovate Therapeutics | N/A | |
| Pedy Harianto | Golden Agri Resources | N/A | |
| Kok Tan | Wilmar International | 49 | |
| William George | Sprott Focus Trust | 66 | |
| Khoo Yeow | Golden Agri Resources | N/A | |
| Ben Bussey | Intuitive Machines | N/A | |
| Kristen MBA | Recursion Pharmaceuticals | N/A | |
| David Hallett | Recursion Pharmaceuticals | 55 | |
| Janelle Gordon | Recursion Pharmaceuticals | N/A | |
| Anna Jones | Intuitive Machines | 44 | |
| Mariana Rezende | Brasilagro Adr | N/A | |
| Susan Fischer | Aerovate Therapeutics | N/A | |
| Stephen Yu | Aerovate Therapeutics | N/A | |
| Jade Marcantel | Intuitive Machines | N/A | |
| LaMei Teo | Wilmar International | 63 | |
| Matthew Morgenroth | Wilmar International | N/A | |
| Marinus Verwijs | Aerovate Therapeutics | 48 | |
| Michael Ellis | Rumble Inc | 39 | |
| Alon Yaari | InMode | N/A | |
Management Performance
GrainCorp Limited Leadership Team
Elected by the shareholders, the GrainCorp's board of directors comprises two types of representatives: GrainCorp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GrainCorp. The board's role is to monitor GrainCorp's management team and ensure that shareholders' interests are well served. GrainCorp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GrainCorp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Cate Hathaway, Interim Group General Manager Human Resources and SHE | ||
| Jesse Scott, Chief Officer | ||
| Robert BE, MD CEO | ||
| LLB BCom, Group Sec | ||
| Luke Thrum, Sr Relations | ||
| Klaus Pamminger, Group General Manager of Marketing | ||
| MBA LLB, Group Officer | ||
| Ian Morrison, Chief Officer |
GrainCorp Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is GrainCorp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.29 | |||
| Return On Asset | 0.2 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 1.75 B | |||
| Shares Outstanding | 223.65 M | |||
| Shares Owned By Insiders | 1.95 % | |||
| Shares Owned By Institutions | 37.37 % | |||
| Price To Earning | 5.02 X | |||
| Price To Book | 1.22 X |
Currently Active Assets on Macroaxis
Other Information on Investing in GrainCorp Pink Sheet
GrainCorp financial ratios help investors to determine whether GrainCorp Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GrainCorp with respect to the benefits of owning GrainCorp security.